These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6274091)

  • 61. A cosmid system for the analysis of lytic replication of Epstein-Barr virus.
    Hung CH; Kwan MJ; Liu ST
    Anal Biochem; 1999 Aug; 272(2):277-80. PubMed ID: 10415101
    [No Abstract]   [Full Text] [Related]  

  • 62. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1.
    Su W; Middleton T; Sugden B; Echols H
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10870-4. PubMed ID: 1660153
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The switch between latency and replication of Epstein-Barr virus.
    Miller G
    J Infect Dis; 1990 May; 161(5):833-44. PubMed ID: 2157769
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 66. On the chromosomal sites of Epstein-Barr virus in Burkitt tumor cell lines.
    Petit P
    Am J Hum Genet; 1984 Mar; 36(2):480-1. PubMed ID: 6324583
    [No Abstract]   [Full Text] [Related]  

  • 67. Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol.
    Adams A
    J Gen Virol; 1973 Sep; 20(3):391-4. PubMed ID: 4355332
    [No Abstract]   [Full Text] [Related]  

  • 68. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.
    Katz BZ; Raab-Traub N; Miller G
    J Infect Dis; 1989 Oct; 160(4):589-98. PubMed ID: 2551973
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters.
    Weigel R; Miller G
    Virology; 1983 Mar; 125(2):287-98. PubMed ID: 6301144
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
    Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
    Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhanced activation of the repressed Epstein-Barr viral genome by inhibitors of DNA synthesis.
    Hampar B; Derge JG; Showalter SD
    Virology; 1974 Mar; 58(1):298-301. PubMed ID: 4362552
    [No Abstract]   [Full Text] [Related]  

  • 72. Induction of latent Epstein-Barr virus information by a serum factor.
    Bauer G; zur Hausen H
    Haematol Blood Transfus; 1983; 28():297-8. PubMed ID: 6305802
    [No Abstract]   [Full Text] [Related]  

  • 73. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
    J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification and characterization of a DNase induced by Epstein-Barr virus.
    Tan RS; Datta AK; Cheng YC
    J Virol; 1982 Dec; 44(3):893-9. PubMed ID: 6294337
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of an Epstein-Barr virus-induced thymidine kinase.
    de Turenne-Tessier M; Ooka T; de The G; Daillie J
    J Virol; 1986 Mar; 57(3):1105-12. PubMed ID: 3005613
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Purification and properties of Epstein-Barr virus DNase expressed in Escherichia coli.
    Stolzenberg MC; Ooka T
    J Virol; 1990 Jan; 64(1):96-104. PubMed ID: 2152838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epstein-Barr virus-induced deoxynuclease and the reutilization of host-cell DNA degradation products in viral DNA replication.
    Feighny RJ; Henry BE; Pagano JS
    Virology; 1981 Dec; 115(2):395-400. PubMed ID: 6274091
    [No Abstract]   [Full Text] [Related]  

  • 78. Studies on the activity of DNase associated with the replication of the Epstein-Barr virus.
    Cheng YC; Chen JY; Hoffmann PJ; Glaser R
    Virology; 1980 Jan; 100(2):334-8. PubMed ID: 6243430
    [No Abstract]   [Full Text] [Related]  

  • 79. Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells.
    Williams MV; Holliday J; Glaser R
    Virology; 1985 Apr; 142(2):326-33. PubMed ID: 2997989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma.
    Heston L; Rabson M; Brown N; Miller G
    Nature; 1982 Jan; 295(5845):160-3. PubMed ID: 6276755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.